Omega-3 concentrates supplier GC Rieber VivoMega names new CEO
Snorre Glærum Strand previously served as finance manager and then CFO for GC Rieber VivoMega.
Pictured: Snorre Glærum Strand. Photo from GC Rieber VivoMega.
GC Rieber VivoMega (Norway), a supplier of omega-3 concentrate ingredients, has named Snorre Glærum Strand its new CEO. Strand previously served as finance manager and then CFO for GC Rieber VivoMega.
Strand holds an MSc in Economics from the Norwegian Business School BI. His previous experience also includes working at AstraZeneca and Nordea Bank. At GC Rieber VivoMega, he worked closely with now-former CEO Jan Roger Bjerkestrand.
“As Snorre steps into the CEO role, the owners of GC Rieber have elected former CEO Jan Roger Bjerkestrand as the new chairman of the board of GC Rieber VivoMega, allowing for a smooth transition and continuation of the fruitful collaboration between the two,” the firm’s press release states. Bjerkestrand added that Strand “has been fundamental in planning the ongoing expansion of the VivoMega production facilities in Kristiansund, where we aim to double the production.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
